Trial Comparing Radiotherapy with Dual Immunotherapy in Locally Advanced Rectal Cancer
A multicenter trial is evaluating the efficacy of different radiotherapy regimens combined with dual immunotherapy in LARC patients.
Indication
Clinical and regulatory intelligence for Rectal Cancer with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.